---
title: "NRx subsidiary HOPE Therapeutics begins patient treatments using Zeta Surgical TMS navigation system"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290819828.md"
description: "NRx Pharmaceuticals subsidiary HOPE Therapeutics has begun treating patients with major depressive disorder using Zeta Surgical’s FDA-cleared Zeta TMS Navigation System at two Florida clinics. This rollout integrates precision-guided outpatient TMS care into HOPE’s interventional psychiatry platform and supports NRX’s upcoming SPARC-TMS trial, which pairs NRX-101 with robotic-enabled TMS across civilian and military sites."
datetime: "2026-06-25T11:02:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290819828.md)
  - [en](https://longbridge.com/en/news/290819828.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290819828.md)
generator: "portal-rs"
---

# NRx subsidiary HOPE Therapeutics begins patient treatments using Zeta Surgical TMS navigation system

-   NRX Pharmaceuticals subsidiary HOPE Therapeutics began treating patients using Zeta Surgical’s FDA-cleared Zeta TMS Navigation System at two Florida clinics. \* Rollout moves HOPE’s interventional psychiatry platform into routine, precision-guided outpatient TMS care for major depressive disorder. \* Deployment supports NRX’s planned SPARC-TMS trial pairing NRX-101 with robotic-enabled TMS across civilian and military treatment sites. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606250700PRIMZONEFULLFEED9752538) on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [NRXP.US](https://longbridge.com/en/quote/NRXP.US.md)
- [NRXPW.US](https://longbridge.com/en/quote/NRXPW.US.md)

## Related News & Research

- [NRX Pharmaceuticals reports $18.0M net loss for first half 2026, $26.7M cash on hand](https://longbridge.com/en/news/296102653.md)
- [HOPE Therapeutics treats first patient using Zeta TMS Navigation System](https://longbridge.com/en/news/290584183.md)
- [NS United Naiko Kaiun to install JMU autonomous navigation system on Kimitetsu Maru](https://longbridge.com/en/news/296718234.md)
- [HRT Financial disposes of 1,380 Zeta Network Group shares worth $2,539.20](https://longbridge.com/en/news/297017592.md)
- [Zeta Network Group initial beneficial ownership statement names HRT Financial as 10% owner](https://longbridge.com/en/news/297014144.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**